Strongbridge Biopharma














This sounds fishy. Old repackaged drug made only 2 million in q3 and that's enough to expand the rep count? Company barely has enough capital to stay afloat thru May of next year.
 


Interesting as I looked at it as well. Looks like they were trying to imitate other companies any way they could - move to Ireland, buy an old product and tell a story. Like the offspring of Allergan and Turing without any of the smarts. Agree.
 


Interesting as I looked at it as well. Looks like they were trying to imitate other companies any way they could - move to Ireland, buy an old product and tell a story. Like the offspring of Allergan and Turing without any of the smarts. Agree.

Washington Post just trashed this company. Basically said they were the next Turing, and management too cowardly to comment. Good place not to work.
 












https://www.washingtonpost.com/news...now-its-109500-a-year/?utm_term=.89207a0604fe

https://endpts.com/a-us-senator-cal...or-price-gouging-but-will-it-change-anything/

This is not exactly like Turing. Sun Pharma did get a new approval which gave it new exclusivity under US law. That was an investment that the company could recoup and they sold the rights to Strongbridge.

I'm not discounting the bad optics, but Turing did no research and was actively blocking others from entry. Turing really were just trying to hike the price and get as much cash as possible.

These guys seem to be working to commercialize the value of the investment made by Sun and then sold to them for a new indication.
 


The drug they are selling and price gouging is basically a generic that they did zero work for. It is in fact the same story as Turing. Somehow I trust the Washington Post.
 


The salesforce has been around for less than a year and there’s already been turnover. Nice salaries, sure but bonuses are on the weak side. And nothing in the pipeline is game changing if that’s what you’re looking for.
 


The salesforce has been around for less than a year and there’s already been turnover. Nice salaries, sure but bonuses are on the weak side. And nothing in the pipeline is game changing if that’s what you’re looking for.
Thanks. Heard there was turnover. Also saw they basically had a failed capital raise they couldn’t compete!
 







Write your reply...